An Open-Label, Phase 1 Study in Healthy Volunteers to Evaluate the Pharmacokinetic Food Effect and Cardiac Safety of CCX168
Latest Information Update: 18 Aug 2023
At a glance
- Drugs Avacopan (Primary)
- Indications Anti-neutrophil cytoplasmic antibody-associated vasculitis
- Focus Pharmacokinetics
- Sponsors Amgen
- 18 Aug 2023 New trial record